Live Breaking News & Updates on Pulmatrix Company Profile Get Rating

Stay updated with breaking news from Pulmatrix company profile get rating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pulmatrix (NASDAQ:PULM) Coverage Initiated by Analysts at StockNews.com

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock. ....

United States , Morgan Stanley , Geode Capital Management , Murchinson Ltd , Pulmatrix Inc , Pulmatrix Company Profile Get Rating , Citadel Advisors , Get Rating , Capital Management , Company Profile ,

Pulmatrix (NASDAQ:PULM) vs. Rocket Pharmaceuticals (NASDAQ:RCKT) Head-To-Head Comparison

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) and Pulmatrix (NASDAQ:PULM – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, institutional ownership and profitability. Valuation and Earnings This table compares Rocket Pharmaceuticals and Pulmatrix’s […] ....

New Jersey , United States , Fundacion Jimenez Diaz , Investigacion Biomedica , Investigaciones Energ , Medioambientalesy Tecnol , Regenxbio Inc , Rocket Pharmaceuticals Company Profile Get Rating , Pulmatrix Inc , Rocket Pharmaceuticals , Regents Of The University California , Rocket Pharmaceuticals Inc , Respivert Ltd , Pulmatrix Company Profile Get Rating , Cipla Technologies , Sensory Cloud Inc , Fred Hutchinson Cancer Research Center , Get Rating , Given Rocket Pharmaceutical , Pharmaceuticals Company Profile , Centro De Investigaciones Energ , Centro De Investigacion Biomedica En Red , Fundacion Instituto , Sanitaria Fundacion Jimenez Diaz , Company Profile , Sensory Cloud ,

Pulmatrix (NASDAQ:PULM) Posts Quarterly Earnings Results, Misses Estimates By $0.83 EPS

Pulmatrix (NASDAQ:PULM – Get Rating) announced its earnings results on Tuesday. The biotechnology company reported ($2.43) earnings per share for the quarter, missing the consensus estimate of ($1.60) by ($0.83), MarketWatch Earnings reports. Pulmatrix had a negative net margin of 283.61% and a negative return on equity of 34.73%. Shares of NASDAQ:PULM traded up $0.11 […] ....

United States , Morgan Stanley , Geode Capital Management , Pulmatrix Inc , Virtu Financial , Zacks Investment Research , Pulmatrix Company Profile Get Rating , Citadel Advisors , Get Rating , Marketwatch Earnings , Capital Management , Company Profile , Small Particles Easily Respirable , Nasdaq Pulm ,

HC Wainwright Raises Pulmatrix (NASDAQ:PULM) Price Target to $10.00

Pulmatrix (NASDAQ:PULM – Get Rating) had its price objective raised by equities researchers at HC Wainwright from $5.00 to $10.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. HC Wainwright’s price objective points to a potential upside of […] ....

United States , Geode Capital Management , Pulmatrix Inc , Virtu Financial , Zacks Investment Research , Murchinson Ltd , Pulmatrix Company Profile Get Rating , Citadel Advisors , Get Rating , Investment Research , Capital Management , Company Profile , Small Particles Easily Respirable , Nasdaq Pulm , Boost Price Target , Hc Wainwright ,